Yasons Chemex Care Limited — Others, 12-11-2024: Statement of deviation(s) or variation(s) under Reg. 32

Yasons Chemex Care Limited has announced a board meeting to review the Statement of Deviation for the half-year ended September 30, 2024, confirming that there has been no deviation in the utilization of funds raised through their SME IPO, amounting to ₹20.57 crore. The funds were allocated primarily for working capital and general corporate purposes, with a minor unutilized balance of ₹1.36 lakh. This consistency in fund usage may enhance investor confidence in the company's governance and operational integrity. Overall, the news reflects a positive outlook for the company, indicating effective financial management and adherence to strategic plans.